Загрузка...
ADVANCING THE MRD CONCEPT IN ACUTE MYELOID LEUKEMIA
The criteria to evaluate response to treatment in acute myeloid leukemia (AML) have changed little in the past sixty years. It is now possible to use higher sensitivity tools to measure residual disease burden in AML. Such minimal or measurable residual disease (MRD) measurements provide a deeper un...
Сохранить в:
| Опубликовано в: : | Semin Hematol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4484880/ https://ncbi.nlm.nih.gov/pubmed/26111465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2015.04.001 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|